PHGE

Biomx Ltd

$2.28

+0.04 (+1.79%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 11.01.2026
$165.00
(+7136.84%)
Strong Buy: 0
Buy: 0
Hold: 0
Sell: 0
Strong Sell: 0
Description:
BiomX Inc. (PHGE) is an innovative clinical-stage company based in Ness Ziona, Israel, focused on developing microbiome-based therapies through both natural and engineered phage technologies. The company's extensive pipeline targets a range of conditions, including inflammatory bowel disease, cystic fibrosis, and acne, addressing significant therapeutic gaps associated with bacterial infections and dysbiosis. BiomX's commitment to pioneering microbial interventions aims to reshape treatment paradigms in healthcare, driving advancements in disease management and improving patient outcomes.
Exchange:
NYSE MKT
Country:
USA
Sector:
HEALTHCARE
Industry:
BIOTECHNOLOGY
Address:
22 EINSTEIN STREET, NESS ZIONA, ISRAEL, 7414003
Fiscal year end:
December
Market capitalization:
$3.48 Million
EBITDA:
-$30.4 Million
PERatio:
0.0
EPS:
-37.05
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.608

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 6 years:
-100%
How much will you get:
$1
Prices dates:
13-03-2019: $1,833.50 and 31-12-2025: $1.87